Modernatx, Inc.

Shinu John

Giuseppe Ciaramella

Kambiz Mousavi

Andrew J Bett

Lan Zhang

Dai Wang

Andrea Carfi

Danilo R Casimiro

Kimberly Hassett

Jack F Kramarczyk

Phil White

Herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.

Herpes simplex virus vaccine

The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Human cytomegalovirus vaccine

The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Human cytomegalovirus RNA vaccines

Aspects of the disclosure relate to methods for producing an antigen-specific immune response to human cytomegalovirus (hCMV) in a subject by administering mRNA vaccines.

HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Growing community of inventors

Somerville, MA, United States of America

Shinu John